Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Puig €2.6 billion IPO
Puig’s Class B shares are listed on the Spanish Stock Exchanges
Finastra Group $5.32 billion refinancing
We advised the administrative agent, lead arrangers and lenders on the refinancing
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
BioNTech $511.5 million share offering and rights offering
Davis Polk advised the representatives of the underwriters in connection with the $511.5 million SEC-registered offering of…
Wyndham Destinations $650 million secured notes offering
Davis Polk advised the joint book-running managers on an offering by Wyndham Destinations, Inc. of $650 million…
InflaRx $50 million at-the-market offering
Davis Polk advised the sales agent in connection with an SEC-registered at-the-market offering by InflaRx N.V. of its…
Inventiva $108 million U.S. IPO and Nasdaq listing
Davis Polk advised the representatives of the underwriters in connection with an initial public offering of Inventiva S…
Centogene $49 million follow-on offering
Davis Polk advised Centogene N.V. on its $49 million follow-on public offering of 3,500,000 of its common shares, consisting…
Outotec Oyj combination with Metso’s minerals business
Davis Polk advised Outotec Oyj as to U.S. law in connection with the demerger by Metso Corporation’s minerals business by…
Hashemite Kingdom of Jordan $1.75 billion notes offering
Davis Polk advised the joint lead managers in connection with the Rule 144A/Regulation S offering by the Hashemite Kingdom…
Harmony Gold Mining $200 million equity private placement
Davis Polk advised the joint global coordinators of a private placement of new ordinary shares of Harmony Gold Mining…
ING Groep $1 billion green bond offering
Davis Polk advised the lead managers in connection with a Rule 144A/Reg S green bond offering by ING Groep N.V. of $1…
Oryzon Genomics €20 million private placement
Davis Polk advised Oryzon Genomics, S.A. on its private placement of approximately 7,273,000 of its ordinary shares pursuant…